Patents by Inventor John C. McMichael

John C. McMichael has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6899885
    Abstract: A protein from M. catarrhalis, designated the 74 kD protein, is isolated and purified. The 74 kD protein has an amino-terminal amino acid sequence which is conserved among various strains of M. catarrhalis. The protein has a molecular weight of approximately 74.9 kD as measured on a 10% SDS-PAGE gel, while its molecular weight as measured by mass spectrometry is approximately 74 kD. The 74 kD protein is used to prepare a vaccine composition which elicits a protective immune response in a mammalian host, to protect the host against disease caused by M. catarrhalis.
    Type: Grant
    Filed: July 26, 2002
    Date of Patent: May 31, 2005
    Assignee: Wyeth Holdings Corporation
    Inventors: Dexiang Chen, Karl R. VanDerMeid, John C. McMichael, Vicki L. Barniak
  • Patent number: 6461618
    Abstract: A protein from the M. catarrhalis designated the 74 kD protein is isolated and purified. The 74 kD protein has an amino-terminal amino acid sequence which is conserved among various strains of M. catarrhalis. The protein has a molecular weight of approximately 74,9 kD as measured on a 10% SDS-PAGE gel, while its molecular weight as measured by mass spectrometry is approximately 74 kD. The 74 kD protein is used to prepare a vaccine composition which elicits a protective immune response in a mammalian host to protect the host again disease caused by M. catarrhalis.
    Type: Grant
    Filed: October 21, 1999
    Date of Patent: October 8, 2002
    Assignee: American Cyanamid Company
    Inventors: Dexiang Chen, Karl R. VanDerMeid, John C. McMichael, Vicki L. Barniak
  • Patent number: 4702911
    Abstract: A method for obtaining bacterium pili subunits directly from specified bacteria is disclosed and claimed. Dependent upon the bacterium from which the pili subunits are to be obtained, the pH of extraction solutions will be adjusted accordingly. Pili subunits obtained in accord with the method of this invention are useful for preparing vaccines which exhibit good protection against heterologous strain infections.
    Type: Grant
    Filed: August 14, 1986
    Date of Patent: October 27, 1987
    Assignee: ImmunoMed Corporation
    Inventor: John C. McMichael
  • Patent number: 4696896
    Abstract: There are provided a crystalline and single rod products derivable from the Pili of Type 1 and Type 2 Neisseria gonorrhoese organisms. There are provided methods of growing said organisms to produce the maximum yield of Pili and procedures for purifying said Pili to produce said crystalline material. There are further provided methods of utilizing said Pili to determine the presence, in a system infectable by N. gonorrhoese organisms, of antibodies to the Pili of said organisms, and methods of serotyping said Pili. There is also provided a mode of utilizing said crystalline material to provide a substantial degree of immunization infection by N. gonorrhoese in mammalian systems susceptible to such infection.
    Type: Grant
    Filed: March 19, 1984
    Date of Patent: September 29, 1987
    Assignee: Bactex, Inc.
    Inventors: Charles C. Brinton, John C. McMichael
  • Patent number: 4461838
    Abstract: There are provided a crystalline and single rod products derivable from the Pili of Type 1 and Type 2 Neisseria gonorrhoeae organisms. There are provided methods of growing said organisms to produce the maximum yield of Pili and procedures for purifying said Pili to produce said crystalline material. There are further provided methods of utilizing said Pili to determine the presence, in a system infectable by N. gonorrhoeae organisms, of antibodies to the Pili of said organisms, and methods of serotyping said Pili. There is also provided a mode of utilizing said crystalline material to provide a substantial degree of immunization to infection by N. gonorrhoeae in mammalian systems susceptible to such infection.
    Type: Grant
    Filed: September 18, 1980
    Date of Patent: July 24, 1984
    Assignee: Bactex, Inc.
    Inventors: Charles C. Brinton, John C. McMichael